| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 44, 1060-1065, Copyright © 1997 by Canadian Anesthesiologists' Society
ARTICLES |
JA Alhashemi, ET Crosby, W Grodecki, PJ Duffy, KA Hull and C Gallant
Department of Anaesthesia, Ottawa General Hospital, University of Ottawa, Ontario.
PURPOSE: To compare both the efficacy and cost of nalbuphine and diphenhydramine in the treatment of intrathecal morphine-induced pruritus following Caesarean section. METHODS: Eighty patients, undergoing elective Caesarean section under spinal anaesthesia, were randomized, in a prospective, double-blind trial, to receive either nalbuphine (Group NAL) or diphenhydramine (Group DIP) for the treatment of SAB morphine-induced pruritus. All patients received an intrathecal injection of 10-12 mg hyperbaric bupivacaine 0.75% and 200 micrograms preservative free morphine. Postoperative pruritus was assessed, using a visual analogue scale (VAS), for 24 hr. Pruritus treatment was administered upon patient request and by a nurse blinded to the treatment given. Patients who failed to respond to three doses of the study drug were deemed treatment failures. Patient satisfaction was assessed with a questionnaire given 24 to 48 hr after surgery. Direct drug costs were calculated based on the pharmacy provision costs as of April 1996. RESULTS: Eighty patients were enrolled and 45 requested treatment for pruritus. Patients treated with NAL (n = 24) were more likely to achieve a VAS score of zero with treatment (83% vs 43%, P < 0.01), had a higher delta VAS following treatment (4 +/- 2 vs 2 +/- 2, P < 0.003), and experienced fewer treatment failures (4% vs 29%, P < 0.04), than those treated with DIP (n = 21). Group NAL patients were also more likely to rate their pruritus treatment as being good to excellent (96% vs 57%, P < 0.004). Direct drug costs were higher for NAL than for DIP ($6.4 +/- 3.1 vs $1.7 +/- 0.7, respectively, P < 0.0001). CONCLUSION: Nalbuphine is more effective than diphenhydramine in relieving pruritus caused by intrathecal morphine and the cost differences are small.
This article has been cited by other articles:
![]() |
N. Nakatsuka, S. C. Minogue, J. Lim, C. J. Montgomery, C. A. Court, S. Malherbe, Y. Csanyi-Fritz, R. A. Kearney, L. Phillips, K. Reid, et al. Intravenous nalbuphine 50 {micro}g{middle dot}kg-1 is ineffective for opioid-induced pruritus in pediatrics: [La nalbuphine intraveineuse a 50 {micro}g{middle dot}kg-1 est inefficace contre le prurit induit par les opioides chez des enfants]. Can J Anesth, November 1, 2006; 53(11): 1103 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ko, D. H. Goldstein, and E. G. VanDenKerkhof Definitions of "respiratory depression" with intrathecal morphine postoperative analgesia: a review of the literature: [Definitions de la "depression respiratoire" de l'analgesie postoperatoire realisee avec de la morphine intrathecale : une revue documentaire] Can J Anesth, August 1, 2003; 50(7): 679 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Charuluxananan, O. Kyokong, W. Somboonviboon, A. Narasethakamol, and P. Promlok Nalbuphine Versus Ondansetron for Prevention of Intrathecal Morphine-Induced Pruritus After Cesarean Delivery Anesth. Analg., June 1, 2003; 96(6): 1789 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Charuluxananan, O. Kyokong, W. Somboonviboon, S. Lertmaharit, P. Ngamprasertwong, and K. Nimcharoendee Nalbuphine Versus Propofol for Treatment of Intrathecal Morphine-Induced Pruritus After Cesarean Delivery Anesth. Analg., July 1, 2001; 93(1): 162 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-H. Tan, Y.-Y. Chia, Y. Lo, K. Liu, L.-C. Yang, and T.-H. Lee Intrathecal bupivacaine with morphine or neostigmine for postoperative analgesia after total knee replacement surgery : [L'administration intrathecale de bupivacaine avec morphine ou neostigmine comme analgesie postoperatoire suivant la mise en place d'une prothese totale de genou] Can J Anesth, June 1, 2001; 48(6): 551 - 556. [Abstract] [Full Text] |
||||
![]() |
T. Breen, T McNeil, and L Dierenfield Obstetric anesthesia practice in Canada Can J Anesth, December 1, 2000; 47(12): 1230 - 1242. [Abstract] |
||||
![]() |
X. Culebras, G. Gaggero, J. Zatloukal, C. Kern, and R.-A. Marti Advantages of Intrathecal Nalbuphine, Compared with Intrathecal Morphine, After Cesarean Delivery: An Evaluation of Postoperative Analgesia and Adverse Effects Anesth. Analg., September 1, 2000; 91(3): 601 - 605. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |